Pancreatic Cancer Research

ResearcherJinan UniversityActive in the last 2 years

Xiaomei Luo

Matched on ORCID iD 0009-0003-7466-6032; OpenAlex author ID A5045041327. Sources: OpenAlex.

Their work

Papers
1
Trials
0
Grants
0
Labs led
0
Collaborators
2
Papers, trials and grants by year

2026: 1 paper

Papers 1

  1. Dual-targeting evodiamine analogue overcomes pancreatic cancer immunotherapy resistance by inducing immunogenic cell death. Co-author DOI 10.1016/j.bcp.2026.118059↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wei Wang · 1 shared paper, 2026 · strength 0.25
  2. Chunquan Sheng · 1 shared paper, 2026 · strength 0.25

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.